Admission Date:  [**2186-4-27**]              Discharge Date:   [**2186-5-2**]  Date of Birth:  [**2143-11-3**]             Sex:   F  Service: MEDICINE  Allergies: Patient recorded as having No Known Allergies to Drugs  Attending:[**First Name3 (LF) 2024**] Chief Complaint: Dizziness and headache  Major Surgical or Invasive Procedure: Right-sided ventriculoperitoneal shunt placement with endoscopic assistance   History of Present Illness: 42y woman with metastatic breast cancer (HER-2 positive) with hepatic involvement, C-spine/L-spine and hip involvement (s/p lumpectomy in [**2180**]; radiation treatment to bony mets; ongoing chemotherapy).
The headache has been mild and easily treated with simple analgaesics (tylenol only).
decadron 4mg was started [**Hospital1 **].
She was admitted to the Oncology [**Hospital1 **] following MRI and received a further 10mg iv dexamethasone and 50g mannitol pending clinical review and review of imaging study.
S/p Cholecystectomy 9 years ago .
She had then received Herceptin as well as carboplatin and Taxol in the hospital and then as an outpatient in late [**2183**].
She also had skeletal metastases that required radiation which was done in [**Location (un) 3844**] (C-spine, L-spine and hip).
Surgical clips related to prior cholecystectomy are again seen.
The peritoneal portion of a ventriculoperitoneal shunt is identified on top of the liver anteriorly.
On review of the MRI report, however, urgent consults to Radiation Oncology, Neurosurgery, and Neuro-oncology were placed.
She received an IV dose of Decadron 10 mg x 1 and Mannitol 50 g x 1.
The following morning she was taken to the OR for placement of a right ventriculoperitoneal shunt.
Her surgical procedure was uncomplicated and she was transferred back to the Oncology service for further care.
She continued on dexamethasone with famotidine as GI prophylaxis.
In discussion of plans for futher care, the decision was made to enroll Ms. [**Known lastname 2152**] in an ongoing clinical trial of WBRT with Lapatinib and Trastuzumab (Herceptin).
She underwent a pre-enrollment TTE and CT torso while in-patient.
She will undergo the first session of radiation therapy on [**5-9**] after she has completed the 14-day chemotherapy washout period.
Medications on Admission: Xeloda Herceptin weekly Zomeda weekly (Trastuzamab)   Discharge Medications: 1.
Dexamethasone 4 mg Tablet Sig: One (1) Tablet PO every six (6) hours.
Famotidine 20 mg Tablet Sig: One (1) Tablet PO Q12H (every 12 hours).
Disp:*60 Tablet(s)* Refills:*1*   Discharge Disposition: Home  Discharge Diagnosis: Brain metastases Metastatic breast cancer   Discharge Condition: Good, neurologically intact   Discharge Instructions: You can keep your abdominal wounds open to air, without any dressings.
You can also keep your head incision open to air without dressings.
You should not wash your hair for the next 10 days, or until otherwise instructed by Neurosurgery.
Followup Instructions: You are scheduled to have your sutures removed on Tuesday, [**5-9**] at 11 a.m.  Dr.[**Name (NI) 9034**] office is located on the [**Location (un) 470**] of the [**Hospital Unit Name **] at [**Last Name (NamePattern1) 20120**]on [**Hospital1 18**] [**Hospital Ward Name 12837**].
You are scheduled to begin brain radiation next Tuesday [**5-9**] at 9:30 a.m. You should come to basement of the Finaird Building on the [**Hospital1 18**] [**Hospital Ward Name 516**].
